CRIS Current Research Information System

ANDRINI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.377
NA - Nord America 1.091
EU - Europa 800
AF - Africa 98
SA - Sud America 90
OC - Oceania 6
Totale 4.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.051
CN - Cina 631
VN - Vietnam 607
SG - Singapore 534
IT - Italia 351
HK - Hong Kong 165
BD - Bangladesh 137
KR - Corea 105
DE - Germania 80
BR - Brasile 68
NL - Olanda 66
IN - India 65
SE - Svezia 55
GB - Regno Unito 46
FI - Finlandia 35
IE - Irlanda 33
JP - Giappone 33
CI - Costa d'Avorio 31
FR - Francia 31
CA - Canada 25
CH - Svizzera 24
RU - Federazione Russa 22
TG - Togo 21
ID - Indonesia 14
JO - Giordania 14
TH - Thailandia 14
ZA - Sudafrica 14
SC - Seychelles 13
PH - Filippine 12
AT - Austria 11
BG - Bulgaria 10
MX - Messico 10
TW - Taiwan 10
TR - Turchia 9
IQ - Iraq 7
PL - Polonia 7
AU - Australia 6
AR - Argentina 5
MA - Marocco 5
CL - Cile 4
EC - Ecuador 4
LT - Lituania 4
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
HU - Ungheria 3
LB - Libano 3
NG - Nigeria 3
PK - Pakistan 3
SA - Arabia Saudita 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CO - Colombia 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AL - Albania 1
BE - Belgio 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
Totale 4.462
Salva come PNG Salva come JPEG
Città #
Singapore 383
Hefei 217
Ashburn 197
Ho Chi Minh City 170
Hong Kong 152
San Jose 146
Hanoi 138
Seoul 99
Santa Clara 87
Bologna 74
Beijing 58
Boardman 37
New York 36
Chandler 34
Los Angeles 34
Dublin 33
Council Bluffs 32
Abidjan 31
Milan 30
Buffalo 27
Tokyo 26
Helsinki 25
Dong Ket 24
Bern 22
Fairfield 22
Dallas 21
Lomé 21
Bengaluru 19
Shanghai 19
Vicenza 19
Biên Hòa 18
Da Nang 18
Frankfurt am Main 17
Haiphong 17
Lauterbourg 17
São Paulo 17
Munich 16
Amman 13
Southend 13
Turin 13
Houston 12
Chicago 11
Hyderabad 11
Rome 11
Amsterdam 10
Guangzhou 10
Johannesburg 10
Montreal 10
Sofia 10
Nuremberg 9
Princeton 9
Quận Bình Thạnh 9
Redondo Beach 9
Tongling 9
Falkenstein 8
Hải Dương 8
London 8
Seattle 8
Woodbridge 8
Wuhan 8
Brooklyn 7
Can Tho 7
Jakarta 7
Lappeenranta 7
Mexico City 7
Modena 7
Tianjin 7
Bến Tre 6
Ha Long 6
Hangzhou 6
Rimini 6
Thái Bình 6
Vienna 6
Düsseldorf 5
Naples 5
Orem 5
Phoenix 5
Shenzhen 5
Toronto 5
Wilmington 5
Bangkok 4
Bensalem 4
Bình Phước 4
Charlotte 4
Florence 4
Istanbul 4
Mumbai 4
Ninh Bình 4
Palermo 4
Poplar 4
Redmond 4
San Francisco 4
Shijiazhuang 4
Thu Dau Mot 4
Warsaw 4
Xi'an 4
Atlanta 3
Baghdad 3
Brasília 3
Bristol 3
Totale 2.776
Salva come PNG Salva come JPEG
Nome #
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 235
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis 229
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review 195
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? 193
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma 185
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 181
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 174
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 169
Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms 168
Bone targeting agents in patients with metastatic prostate cancer: State of the art 165
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies 164
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 164
An Update on Appendiceal Neuroendocrine Tumors 161
Classic versus innovative strategies for immuno-therapy in pancreatic cancer 153
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations 147
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort 144
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading? 136
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis 120
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 117
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges 114
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC 99
β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients 96
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities 91
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 86
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer 80
Non-small-cell lung cancer: how to manage RET-positive disease 78
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature 77
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities 74
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysis 65
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm 65
Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids 63
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: Rationale and clinical implication 59
Antibody–drug conjugates for lung cancer in the era of personalized oncology 52
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms 51
Determinants of incidence trends in pancreatic neuroendocrine neoplasms 51
Multifocal paraneoplastic encephalitis associated with anti-GABA-B and anti-Hu antibodies manifesting with status epilepticus and epilepsia partialis continua: Expanding the clinical-radiological spectrum 51
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib 44
Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer 32
Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives 31
Totale 4.559
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022110 0 0 2 4 8 3 3 19 10 6 40 15
2022/2023346 12 28 8 13 15 25 30 32 73 25 34 51
2023/2024158 9 17 6 12 9 35 13 19 6 16 9 7
2024/2025939 49 56 76 64 119 54 61 44 25 82 86 223
2025/20262.893 269 396 190 189 203 102 339 115 493 217 215 165
Totale 4.559